CHA CHA
Company Profile ↓Company Overview
CHA (CHA) is a publicly traded company listed on with a market capitalization of $2.41B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 16.0%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 15.6%.
Revenue has grown at a 197.2% CAGR over the past five years.
Trades at an undemanding P/E of 1.8.
Carries low leverage with a debt-to-equity ratio of 0.17.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue +4.0%, earnings -53.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 197.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 197.21% |
| 1 Year: | 4.05% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -53.45% |
Stock Price Performance
| 1 Year: | -46.02% |
| 6 Months: | -0.63% |
| 3 Months: | +0.83% |
| 1 Month: | -1.08% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)44.15 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 197.2% over 5 years.
CONS
- Trading 50.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 3.39B | 3.33B | 3.21B | 2.97B | 3.55B |
| Cost of Revenue | - | 1.75B | 1.72B | 1.75B | 1.77B | 2.07B |
| Gross Profit | - | 1.65B | 1.61B | 1.46B | 1.21B | 1.47B |
| Operating Expenses | - | 824.61M | 1.50B | 1.00B | 1.24B | 927.13M |
| Operating Income | - | 820.78M | 107.61M | 454.40M | -35.55M | 547.16M |
| EBITDA | - | 820.78M | 107.61M | 454.40M | -35.55M | 569.00M |
| Interest Expense | - | - | - | - | - | 1.07M |
| Pretax Income | - | 836.06M | 203.64M | 506.35M | 72.03M | 567.93M |
| Tax Provision | - | 158.75M | 126.40M | 108.49M | 38.10M | 120.26M |
| Net Income | - | 678.86M | 69.54M | 394.21M | 28.54M | 450.33M |
| Diluted EPS | - | 3.54 | 0.36 | 2.03 | 0.15 | 2.34 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Mar 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 491.65M | 4.64B | 12.41B | - | 12.91B |
| Cost of Revenue | 358.58M | 2.67B | 6.72B | - | 6.99B |
| Gross Profit | 133.07M | 1.97B | 5.68B | - | 5.92B |
| Operating Expenses | 248.91M | 897.43M | 2.79B | - | 4.57B |
| Operating Income | -115.84M | 1.07B | 2.89B | - | 1.35B |
| EBITDA | -110.93M | 1.08B | 2.95B | - | 1.49B |
| Interest Expense | - | - | - | - | - |
| Pretax Income | -112.38M | 1.01B | 3.04B | - | 1.62B |
| Tax Provision | -21.66M | 203.76M | 527.51M | - | 431.74M |
| Net Income | -90.72M | 800.90M | 2.52B | - | 1.17B |
| Diluted EPS | - | 3.95 | 12.99 | 8.27 | 6.18 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | 393.96M | 2.94B | 6.60B | 11.46B |
| Current Assets | 275.69M | 2.65B | 5.44B | 8.85B |
| Cash & Equivalents | 200.75M | 2.32B | 4.75B | 7.61B |
| Inventory | 33.19M | 41.49M | 132.07M | 228.01M |
| Receivables | 18.91M | 92.77M | 121.97M | 145.90M |
| Total Liabilities | 348.94M | 1.65B | 3.84B | 3.89B |
| Current Liabilities | 297.65M | 1.45B | 2.30B | 2.85B |
| Long Term Debt | - | - | - | - |
| Total Debt | 63.45M | 108.84M | 548.06M | 1.27B |
| Total Equity | 44.95M | 1.28B | 2.65B | 7.34B |
| Shares Outstanding | 183.55M | 183.55M | 189.25M | 219.51M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Mar 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | 27.1% | 42.5% | 45.8% | - | 45.8% |
| Operating Margin % | -23.6% | 23.1% | 23.3% | - | 10.4% |
| Net Margin % | -18.5% | 17.3% | 20.3% | - | 9.1% |
| ROE % | -201.8% | 62.5% | 94.8% | - | 16.0% |
| ROCE % | -120.3% | 72.2% | 67.2% | - | 15.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CHA
Chagee (CHA): The Fastest Growing Consumer Stock to Buy Now - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxONFh3OWM0VUlPaFAzOU5PblJlUFNNQzE0T25tX3BpUmYwNm1abVNmcDBDOFFkUFhNOFB2NENsMWloTVFZdWZCRkR1QmpZaU9hYzlHWGIza1NDTUF3QXE3aTdySjB6OG40cFNBcFRtcm1neFNOZDlKZ3hGZHVYbEVpWVZ2M1dwQ0pYeU5fVV…
Crushed by Kospi rout, angry Koreans rip Lee and vow not to buy - Fortune
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxNYnE0UEEwZVNsQXpHSG1ETDhBeFIzY3dQOGhOMnVEWkRzM2xTY2NzdGFyQzAyN09udGZOaVdfclJiZ21DSERMbWVMcUg4UFdXbnB0UEEtbXdBNjJVODduNVgwVUpKeVNuZTQyYmJaakJpSi0yaEJUYmxMR0ZGS0QxWjVNV0w4RFhKYW0yRl…
ETFs Investing in CHA Biotech Co., Ltd. Stocks - TradingView
<a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTE1Cd2VkTEFENkdhcS1sM1U0OG55UHBIam5EQVRPNGNlVGlNbkpqZlZ4d0pNb19mNUdEdDFIRUVLTDJRZURXR3pHclhrSE5KalkzMGZvb2p6X3B4UmphNnhSTTFB?oc=5" target="_blank">ETFs Investing in CHA Biotech Co., …
Insider Sale: EVP & Chief Mfg and Supply Cha of $ISRG Sells 28 Shares - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOREF3elJkZG1UaHE2NExyRlJHRXdkSWxmRVZ6dUZENFlhbVhoWVBNbnlpUGlPMndoZlU3QW5pT1Mxb2N1M2swZXQ5dmlZVHROM3VVQ3lDOFdqb3BrbTVTNklWS0lxQ3N3UFVkMm9MdWdIN3U0OThUS3VGQmZsMjJoVE9Od3ZHRlBodkNSX0…
Cha Joo-young Shares Okinawa Leisure After Recovery - 조선일보
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNN3dVX0lXMXJGRjNGQVg4aF9YV19xOFVqZzE4UGZYcUQ3SEZnWWFUazkwLXJaWFNnMzFYZlE4a3lVamU5VVZPd1VHWlZsTjV3c1pUUFo4WW16c3lMVzJIbm91Sm5qRUpuWTdzYW9IV0lPTVpsbGxNd2JLMW9QV3N6VXBTaFk5UXYybmpvZz…
Chagee (CHA) Stock Still Looks Cheap After A 57% Slide - simplywall.st
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxNUC1tdUlWcU9STUZxRUtuWGlSWHh0dFpRSlh4X0xZRlF6eUhCZmxDM1Ruc0J1OUpXLVN4TW9YMnpVd1Ewb3FjczJzQklxTmJVVXZJVXF6NmFjbUp1SllpcmFDWGlhWjJGYXQtdFR1dlNpeEVEZUI3LXRBeWd0cXprQk1pcGx2NzliVW9TN3…
CHA — Frequently Asked Questions
What is the current share price of CHA?
As of 2026-08-05 17:25 PDT, CHA trades at $10.97 on NASDAQ/NYSE. Its 52-week range is $9.16 to $21.92.
What is the market capitalisation of CHA?
CHA has a market capitalisation of $2.41B on NASDAQ/NYSE.
What is the P/E ratio of CHA?
CHA trades at a trailing price-to-earnings (P/E) ratio of 1.78. Its price-to-book (P/B) ratio is 0.33.
What is the return on equity (ROE) of CHA?
CHA has a return on equity (ROE) of 15.95%. Its return on capital employed (ROCE) is 15.64%.
Is CHA a good stock to buy?
This page provides a data-driven analysis of CHA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.